July 1, 2026

Nanobody-based anti-CD5 CAR T agent improves efficacy in relapsed or refractory T-cell ALL

China flag

China NMPA grants accelerated approval to rocbrutinib in relapsed or refractory mantle cell lymphoma

SOHO Insider Editors June 28, 2026

The NMPA approval was based on data from the phase 2 ROCK-1 study evaluating rocbrutinib monotherapy in patients with MCL who had relapsed or were refractory after prior treatment with covalent BTK inhibitors. As of June 5, 2025, clinical trial data showed an objective response rate of 63.9%, a complete response rate of 23%, and a median duration of response of 16.5 months.

Read More ➔
Load More

Top Categories

Home

Cellular Therapy
Home

Leukemia
Home

Lymphoma
Home

Multiple Myeloma
Home

Myelodysplastic Syndromes
Home

Myeloproliferative Neoplasms

POPULAR NEWS

SOHO Insider Podcast

ASCO 2026, Trending now, Multiple Myeloma, SOHO Insider Podcast

Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma

Trending now, Lymphoma, Aggressive B-Cell Lymphomas, SOHO Insider Podcast

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

SOHO UK, Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, News, SOHO Insider Podcast

Dr. Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

SOHO 2026, Leukemia, Acute Lymphoblastic Leukemia, News, SOHO Insider Podcast, Society Updates

Public-private partnerships needed to sustain progress in blood cancer treatment

Lymphoma News, SOHO 2025, Lymphoma, Mantle Cell Lymphoma, SOHO Insider Podcast

Drs. Melody, Phillips talk glofitamab in MCL

Myeloproliferative Neoplasms, SOHO Insider Podcast

Advances in essential thrombocythemia with Drs. Kuykendall, Tremblay

Cellular Therapy, Multiple Myeloma, SOHO Insider Podcast

Dr. Thomas Martin interviews 1st US patient treated with cilta-cel

Trending now, Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, SOHO Insider Podcast

Tara Graff, DO, talks community care and the CAR-T vs bispecific debate

Multiple Myeloma, SOHO Insider Podcast

Does the future of myeloma treatment belong to trispecific antibodies?

Leukemia, Chronic Lymphocytic Leukemia, SOHO Insider Podcast

Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL

SBBC, Multiple Myeloma, SOHO Insider Podcast, Video Interviews, Society Updates

Sagar Lonial, MD, on what to expect at SOHO Breakthroughs in Blood Cancers

Leukemia, Acute Myeloid Leukemia, SOHO Insider Podcast

Dr. Eytan Stein joins Dr. Saad Usmani on SOHO Insider podcast

News, SOHO Insider Podcast

Drs. Kuykendall and Gerds discuss myelofibrosis anemia challenges

Leukemia, Chronic Lymphocytic Leukemia, News, SOHO Insider Podcast

SOHO Insider leukemia podcast with Drs. O’Brien and Coombs

Lymphoma, Indolent B-Cell Lymphomas, SOHO Insider Podcast

Dr. Melody interviews Dr. Prica on Burkitt’s lymphoma NEJM paper

SOHO 2025, Meeting News, Myelodysplastic Syndromes, News, SOHO Insider Podcast

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Multiple Myeloma, SOHO Insider Podcast

The journey of belantamab mafodotin in multiple myeloma

Leukemia, Acute Myeloid Leukemia, News, SOHO Insider Podcast

Inside AML challenges with Drs. Jabbour, Daver

Myeloproliferative Neoplasms, SOHO Insider Podcast

Drs. Kuykendall and Hobbs on MPN care in 2025

News, SOHO Insider Podcast

Gwen Nichols speaks with Saad Usmani on CAR-T therapy advances

SOHO Insider Podcast

For CML, the science is here now access must follow

Trending Now

Fundraising
SOHO 2026, Trending now, Meetings / Conferences, News, Society Updates
Grab your SOHO t-shirts during SOHO 2026!
Doctor holding an ipad
EHA 2026, Trending now, Myeloproliferative Neoplasms, Primary Myelofibrosis
Study identifies 4 clinically distinct myelofibrosis subtypes that have different survival prognoses
ASCO 2026, Trending now, Multiple Myeloma, SOHO Insider Podcast
Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma
ASCO 2026, Trending now, Meetings / Conferences, Multiple Myeloma, News
Dr. Hans Lee on MRNA-2808 in relapsed or refractory multiple myeloma
ASCO 2026, Trending now, News
Pemivibart safe, effective for prevention of COVID-19 in immunocompromised cancer patients
Trending now, Community Oncology, Leukemia, Myelodysplastic Syndromes, Video Interviews
What are the barriers to research in the community oncology setting?
SOHO 2026, Trending now, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Aggressive B-Cell Lymphomas, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, T-Cell Lymphoma, News, Society Updates
Submit an abstract for SOHO 2026 by May 15
Naval Daver
Trending now, Leukemia, Acute Myeloid Leukemia, News
Pathways & Perspectives with Naval Daver, MD
Trending now, Lymphoma, Aggressive B-Cell Lymphomas, SOHO Insider Podcast
Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer
Community Oncology News, Trending now, Community Oncology, News
Dr. Fletcher on barriers to sustaining research outside of academia
May and June issue
Trending now, Lymphoma, Aggressive B-Cell Lymphomas, News
Global trial gaps in representation complicate US drug approvals
Community Oncology News, Trending now, Lymphoma, Aggressive B-Cell Lymphomas, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, T-Cell Lymphoma, Video Interviews
Watch: Dr. Krish Patel on building partnerships between community and academic centers
FDA laptop
Trending now, Multiple Myeloma
OPN-6602 in MM granted FDA Fast Track Designation
Trending now, ASH 2025, Leukemia, Acute Lymphoblastic Leukemia, News, Video Interviews
Drs. Zheng and Bona discuss financial toxicity in pediatric ALL
SOHO Insider
Trending now, ASH 2025, Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Video Interviews
Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS
Chase with his family and newborn grandchild.
Trending now, Cellular Therapy, Multiple Myeloma, News
‘A stretch of normal life’ as myeloma patients enter uncharted era
Phase 1 PROMISE Trial Updates
Trending now, ASH 2025, Myeloproliferative Neoplasms, Primary Myelofibrosis
Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis
Doctor holding an ipad
Trending now, Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, News
Phase 1 study of menin inhibitor terminated early due to lack of response, differentiation syndrome
Trending now, Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, SOHO Insider Podcast
Tara Graff, DO, talks community care and the CAR-T vs bispecific debate
Trending now, Society Updates, Young Investigator Program
SOHO Young Investigator Spotlight: Meet Andres Ramirez, MD

Meetings

EHA 2026, Cellular Therapy, Leukemia, Acute Lymphoblastic Leukemia, Meetings / Conferences
Nanobody-based anti-CD5 CAR T agent improves efficacy in relapsed or refractory T-cell ALL
EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis, Video Interviews
Early-phase trial data of INCA033989 shows durable responses in MF
keyboard
EHA 2026, Multiple Myeloma
MajesTEC-3 trial post-hoc analysis: Teclistamab regimen boosts survival across risk in myeloma
AACR 2026, Acute Myeloid Leukemia, Myelodysplastic Syndromes, News, Video Interviews
John DiPersio, MD, PhD, on the future of blood cancers
ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis, Video Interviews
Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial
ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, News
John Mascarenhas, MD, discusses the phase 3 SENTRY trial
Fundraising
SOHO 2026, Trending now, Meetings / Conferences, News, Society Updates
Grab your SOHO t-shirts during SOHO 2026!
Insider_YT_Feature_Pannunzio_CLFR2_400x400[15]
AACR 2026, Acute Lymphoblastic Leukemia, News, Video Interviews
Nicholas Pannunzio, PhD, discusses Ph-like ALL and CRLF2 rearrangement
EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis
Post-transplant molecular monitoring could prompt preemptive intervention in patients with myelofibrosis
Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope
EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis
Novel germline JAK2 mutation linked to progression to MF in MPN
EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis
ERNEST-3 analysis characterizes prevalence of cytopenic MF and treatment trends 
Doctor holding an ipad
EHA 2026, Trending now, Myeloproliferative Neoplasms, Primary Myelofibrosis
Study identifies 4 clinically distinct myelofibrosis subtypes that have different survival prognoses
EHA 2026, Meetings / Conferences, Multiple Myeloma
Study identifies new standard of care for relapsed or refractory MM in the second line
EHA 2026, ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms
Patients with myelofibrosis and anemia respond to antihemojuvelin drug
Doctor at laptop
ASCO 2026, Acute Myeloid Leukemia, News
Which AML patients get lasting benefit from olutasidenib?
Dr. Marc Hoffman
ASCO 2026, Lymphoma, Aggressive B-Cell Lymphomas, Meetings / Conferences, News
Dr. Marc Hoffman discusses results from the GOLSEEK-1 trial of golcadomide in frontline ABCL
Microscope in AI virtual pattern
ASCO 2026, Cellular Therapy, Multiple Myeloma, News
Anito-cel manufacturing builds on CAR T-cell learnings in multiple myeloma trials
ASCO 2026, Trending now, Multiple Myeloma, SOHO Insider Podcast
Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma
ASCO 2026, Cellular Therapy, News
Data support COVID-19 vaccination in patients receiving CAR-T therapy
ASCO 2026, Trending now, Meetings / Conferences, Multiple Myeloma, News
Dr. Hans Lee on MRNA-2808 in relapsed or refractory multiple myeloma
Doctor Inspecting Samples in Lab
ASCO 2026, Aggressive B-Cell Lymphomas, News
Largest study of rare HHV8+ DLBCL identifies risk factors associated with poor survival
vaccination
ASCO 2026
Study finds mRNA COVID-19 vaccination is safe for patients receiving bispecific antibody treatment
clinical trial
ASCO 2026, Lymphoma, Aggressive B-Cell Lymphomas
Frontline tafasitamab, lenalidomide plus R-CHOP improves outcomes in B-cell lymphomas
hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test
ASCO 2026, Aggressive B-Cell Lymphomas, News
Addition of ibrutinib to R-da-EPOCH in HIV-related DLBCL may improve survival outcomes
ASCO 2026, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Lymphoma, T-Cell Lymphoma, Meetings / Conferences
Oncologist migration patterns in the US may drive geographical care disparities
ASCO 2026, Trending now, News
Pemivibart safe, effective for prevention of COVID-19 in immunocompromised cancer patients
Marc Hoffman
ASCO 2026, Lymphoma, Aggressive B-Cell Lymphomas, Meetings / Conferences
Golcadomide improves first-line treatment for aggressive B-cell lymphoma

Young Investigator Program

Maha Hameed
Multiple Myeloma, News, Society Updates, Young Investigator Program
SOHO Young Investigator spotlight: Meet Maha Hameed, MD
Lymphoma News, Leukemia News, SOHO 2025, News, Young Investigator Program
Next-gen hem/oncs engage in new CLL/SLL educational pilot program at SOHO 2025
Leukemia, Young Investigator Program
Dr. Gonzalez Lugo reflects on the SOHO YIP award
Trending now, Society Updates, Young Investigator Program
SOHO Young Investigator Spotlight: Meet Andres Ramirez, MD
Megan Melody, MD
Cellular Therapy, Lymphoma, News, Society Updates, Young Investigator Program
SOHO Young Investigator Spotlight: Meet Megan Melody, MD

Ambassador Program

Anthony Goldstone
Ambassador Program, Leukemia, Acute Lymphoblastic Leukemia, News, Society Updates
Anthony Goldstone built a transplant program. It started in a broom cupboard.
Microscope in AI virtual pattern
SOHO 2025, Ambassador Program, Lymphoma, Aggressive B-Cell Lymphomas, Multiple Myeloma, News
Dr. Raheel Iftikhar weighs in on AI in blood cancers
Janet_800x600
Ambassador Program, News, Society Updates
SOHO strengthens global leadership in blood cancer research
SOHO Turkey
Ambassador Program, News, Society Updates
13th annual SOHO Türkiye meeting to be held April 24–26, 2026
Charles Craddock
SOHO UK, Ambassador Program
Prof. Craddock discusses 1st SOHO UK set for 3–4 March 2026 in London
Bor-Sheng Ko
SOHO Asia 2026, Ambassador Program, News, Video Interviews
Dr. Bor-Sheng Ko discusses the future of SOHO Asia and regional collaborations
Yu-Hung Wang
SOHO Asia 2026, Ambassador Program, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, News
Yu-Hung Wang, MD, PhD, discusses unmet needs in myeloid neoplasms at SOHO Asia
SOHO Israel banner
Ambassador Program, News, Society Updates
Registration is open for 4th SOHO Israel Annual Meeting
SOHO Asia 2026 sign
SOHO Asia 2026, Ambassador Program
SOHO Asia debuts in Taipei with 400 attendees from across Asia-Pacific region
Dr. Hsin-An Hou
SOHO Asia 2026, Ambassador Program, News, Society Updates
1st SOHO Asia hopes to empower hematology community across Asia
Ambassador Program, News, Society Updates
1st SOHO Asia to be held in January 2026
SOHO Egypt attendees
Ambassador Program, News, Society Updates
SOHO Egypt 2025 debuts with 2-day meeting in Cairo
Ambassador Program, News, Society Updates
SOHO KSA holds 3rd successful regional meeting
Presenter speaking
Ambassador Program, Myelodysplastic Syndromes, Society Updates
SOHO MENA returns to in-person meeting for region’s 3rd meeting
SOHO 2025, Ambassador Program, News
The global impact of SOHO
Ambassador Program, News, Society Updates
SOHO regional meeting in Brazil delivers again
SOHO Israel attendees in Tel Aviv for SOHO meeting
Ambassador Program, News, Society Updates
SOHO Israel 2025 wraps up successful 2-day event with leading hematologists
SOHO Spain audience watching hematology presentation.
Ambassador Program, Society Updates
1st SOHO Spain debuts in Madrid, bringing together global hematologists
MEMBERS

About Us/Editorial Board

SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.

A global hematologic oncology medical community

Download the SOHO365 mobile app & join our Ask-the-Expert forums

Submit your difficult clinical questions to the Ask-the-Expert forum in the SOHO mobile app. Submit your questions in our exclusive members-only forums community on the SOHO mobile app. Your inquiry will be sent directly to leading experts, including Dr. Hagop Kantarjian, Dr. Kami Maddocks, Dr. Sagar Lonial, and Dr. Mascarenhas for their insights.

Follow the instructions below to ask a question now!

Members Strong

Join Us Today and Become a Part of the SOHO Community

Benefits of membership include:

  • Instant connections to our SOHO Community of nearly 11,000 members
  • Access to a comprehensive Resource Center that includes slides, publications, abstracts, videos & more
  • Connection to our Ask-the-Expert forums and SOHO DocMatter Community for hematologic oncology discussions and education through our SOHO365 app
  • Free online access to our official journal, Clinical Lymphoma Myeloma and Leukemia
  • Free online and print subscription (US members) to our news publication, SOHO Insider
  • Significant member-only discounts on meetings and events
  • Early member-only registration and housing opportunities
  • ... and much more!
Join Now
Career

SOHO Career Center

The Career Center provides SOHO members with the ability to find jobs in the field of Hematologic Oncology along with a variety of career advice. Select the 'Career Center' button to explore new job opportunities and career information.

The Career Center Allows SOHO Members to:

  • Create a job seeker profile
  • Perform intuitive searches for new jobs
  • Auto-fill your resume through uploaded files
  • Apply to new jobs through a streamlined workflow
  • Receive email alerts when new relevant jobs are posted

To access the SOHO Career Center click the following link.

CAREER CENTER